Safe use of tocilizumab in pregnant women with Takayasu arteritis: three case studies
Saved in:
Main Authors: | Yoshikazu Nakaoka, Nao Konagai, Jun Yoshimatsu, Yoshihiro Nishida, Chizuko Aoki Kamiya, Atsushi Nakanishi, Naoko Iwanaga, Masami Sawada, Aiko Kakigano, Takeshi Kanagawa, Satoshi Eto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-02-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/1/e002996.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
by: Patrice Cacoub, et al.
Published: (2023-06-01) -
Takayasu arteritis
by: N.V. Bortnyak, et al.
Published: (2020-10-01) -
Optimizing corticosteroid therapy in takayasu arteritis
by: Pallavi Patro
Published: (2022-01-01) -
Imaging of takayasu arteritis with renal infarct
by: Niranjan Dhanaji Kanase, et al.
Published: (2021-01-01) -
Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis
by: Takahiko Sugihara, et al.
Published: (2025-01-01)